Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of CareMin650 Used for the Prevention of Oral Mucositis in Patients With Head and Neck Cancer Starting Radiotherapy: the PrOMiSE Study

NCT04699487 is registered in ClinicalTrials.gov with NeoMedLight as lead sponsor.

NCT NCT04699487
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04699487 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of CareMin650 Used for the Prevention of Oral Mucositis in Patients With Head and Neck Cancer Starting Radiotherapy: the PrOMiSE Study
Lead sponsor
NeoMedLight
Phase
Not applicable
Overall status
Completed
Start date
May 10, 2021
Completion date
June 30, 2022
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer, oral mucositis (ulcerative) due to radiation, radiation therapy complication